Venturi Wealth Management’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-80
Closed -$1.48K 1017
2024
Q4
$1.48K Hold
80
﹤0.01% 1884
2024
Q3
$1.74K Hold
80
﹤0.01% 1688
2024
Q2
$1.57K Hold
80
﹤0.01% 1401
2024
Q1
$1.74K Hold
80
﹤0.01% 1272
2023
Q4
$2.31K Hold
80
﹤0.01% 1183
2023
Q3
$2.14K Hold
80
﹤0.01% 1157
2023
Q2
$2.96K Hold
80
﹤0.01% 841
2023
Q1
$2.5K Buy
+80
New +$2.58K ﹤0.01% 966

Other funds holding FLGT

Venturi Wealth Management's FLGT Position: Q1 2025 in Review

Venturi Wealth Management sold out of Fulgent Genetics (FLGT) in Q1 2025, closing a stake of 80 shares — an estimated $1.48K sold.

Venturi Wealth Management first reported a position in FLGT in Q1 2023 and held it in 8 quarters. The position peaked at $2.96K in Q2 2023. 176 funds tracked by Wall St. Rank hold FLGT as of Q1 2025.

  • Venturi Wealth Management reported no remaining Fulgent Genetics position as of Q1 2025 after selling out during the quarter.
  • Venturi Wealth Management sold 80 Fulgent Genetics shares in Q1 2025, an estimated $1.48K.
  • Venturi Wealth Management first reported a position in Fulgent Genetics in Q1 2023 and held it in 8 quarters.
  • Venturi Wealth Management's Fulgent Genetics position peaked at $2.96K in Q2 2023.
  • 176 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2025.

Based on Venturi Wealth Management's 13F filing for Q1 2025, filed 6 May 2025.